Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis, Pancreatectomy and Other Conditions Except Cystic Fibrosis
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis, Pancreatectomy and Other Conditions Except Cystic Fibrosis
This study aims at collecting the information related to the safety and effectiveness in the pancreatic exocrine insufficiency patients receiving the treatment with LipaCreon for a long term in order to evaluate the effective and safe use of LipaCreon.
Criteria for evaluation:
Adverse events
Nutritional endpoints
Symptoms related to exocrine pancreatic insufficiency
Patient's quality of life (QOL)
Degree of general improvement
Inclusion Criteria
Exclusion Criteria
Ehime, 790-0067, Japan
Ehime, 790-8524, Japan
Ehime, 790-8524, Japan
Ehime, 799-0193, Japan
Gunma, 371-8511, Japan
Gunma, 373-8585, Japan
Gunma, 379-2311, Japan
Hokkaido, 001-0033, Japan
Hokkaido, 003-0006, Japan
Hokkaido, 006-0811, Japan
Hokkaido, 006-0811, Japan
Hokkaido, 006-0832, Japan
Hokkaido, 047-8550, Japan
Hokkaido, 053-8567, Japan
Hokkaido, 060-0033, Japan
Hokkaido, 060-8543, Japan
Hokkaido, 060-8648, Japan
Hokkaido, 085-0822, Japan
Hokkaido, 098-5551, Japan